Regulacje i polityka gospodarcza · 22/09/1994

FDA Publishes Draft Guideline on Impurities in New Drug Substances

The FDA is releasing a draft guideline on impurities in new drug substances, developed by the ICH Quality Expert Working Group, to help applicants meet regulatory requirements for drug marketing registration.